Free Brief in Opposition to Motion - District Court of Colorado - Colorado


File Size: 51.9 kB
Pages: 3
Date: November 16, 2006
File Format: PDF
State: Colorado
Category: District Court of Colorado
Author: unknown
Word Count: 832 Words, 5,134 Characters
Page Size: 610 x 790 pts
URL

https://www.findforms.com/pdf_files/cod/20882/130-4.pdf

Download Brief in Opposition to Motion - District Court of Colorado ( 51.9 kB)


Preview Brief in Opposition to Motion - District Court of Colorado
Case 1:03-cv-02579-RPM

Document 130-4

Filed 11/16/2006

Page 1 of 3

Case 1:03-cv-02579-RPM
Slip Copy Slip Copy, 2006 WL 2241018 (D.Del.) (Cite as: Slip Copy)

Document 130-4

Filed 11/16/2006

Page 2 of 3
Page 1

Briefs and Other Related Documents Proctor & Gamble Co. v. Teva Pharmaceuticals USA, Inc.D.Del.,2006.Only the Westlaw citation is currently available. United States District Court,D. Delaware. THE PROCTOR & GAMBLE COMPANY, Plaintiff, v. TEVA PHARMACEUTICALS USA, INC., Defendant. No. Civ.A. 04-940-JJF. Aug. 4, 2006. Frederick L. Cottrell, III, Steven J. Fineman, Richards, Layton & Finger, Wilmington, DE, for Plaintiff. Adam Wyatt Poff, Josy W. Ingersoll, Young, Conaway, Stargatt & Taylor, Wilmington, DE, for Defendant. MEMORANDUM ORDER FARNAN, J. *1 Pending before the Court is Defendant Teva Pharmaceuticals USA, Inc.'s Motion To Preclude The Testimony Of Plaintiff's Patent Law Expert (D.I.69). For the reasons discussed, the Motion will be granted in part and denied in part. I. BACKGROUND In this patent infringement case, Defendant argues that Plaintiff's patent, U.S. Patent No. 5,583,122 ("the '122 patent") is invalid because of obviousness-type double patenting. Plaintiff submitted the Rebuttal Expert Report of Jerry D. Voight in response to Defendant's Expert Report of George R. Lenz, Ph.D., to address patent interference practices and whether the one-way or two-way test should be used for determining obviousness-type double patenting in this case. (D.I. 70 Ex. A). On July 6, 2006, Defendant filed the instant Motion to preclude Plaintiff from proffering Mr. Voight's testimony on any of the opinions set forth in his expert report. (D.I.69). Defendant contends that Mr. Voight's testimony would exceed the scope permitted by the Court because it will include

legal conclusions and goes beyond the practices and procedures of the U.S. Patent and Trademark Office (PTO). (D.I. 69 at 3). In Response, Plaintiff contends that Mr. Voight's expert testimony is within the parameters permitted by the Court because it includes the workings of the PTO and the prosecution history in this case. (D.I.74). Plaintiff's answering brief included an Amended Rebuttal Expert Report of Jerry D. Voight, removing certain legal conclusions, and now contends that Defendant's concerns are moot. FN1 (D.I. 74 Ex. A). FN1. For the purposes of its review of this Motion, the Court considers only the Amended Rebuttal Expert Report of Jerry D. Voight (D.I. 74 Ex. A). II. DISCUSSION A court has broad discretion to admit or exclude evidence under the Federal Rules of Evidence. Gumbs v. Int'l Harvester, Inc., 718 F.2d 88, 97 (3d Cir.1983). Federal Rule of Evidence 702 states that If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case. Fed.R.Evid. 702. The Rules of Evidence do not permit expert testimony as to legal conclusions. Salas by Salas v. Wang, 846 F.2d 897, 905 n. 5 (3d Cir.1988); see Fed.R.Evid. 704. This Court excludes testimony by patent law experts on substantive issues of patent law. (D.I. 70 Ex. C, D); Revlon Consumer Prods. Corp. v. L'Oreal S.A., 1997 U.S. Dist. LEXIS 4117, at *9-10 (D.Del. March 26, 1997). Testimony by Mr. Voight must therefore be restricted to PTO practice and procedures and may not include legal conclusions or substantive is-

© 2006 Thomson/West. No Claim to Orig. U.S. Govt. Works.

Slip Case 1:03-cv-02579-RPM Copy Slip Copy, 2006 WL 2241018 (D.Del.) (Cite as: Slip Copy)

Document 130-4

Filed 11/16/2006

Page 3 of Page 2 3

sues of patent law. In response to Defendant's Motion, Plaintiff's expert removed his legal opinions on two-way testing in the Amended Rebuttal Expert Report. (D.I. 74 Ex. A). Plaintiff agrees to refrain from soliciting Mr. Voight's opinion about which test for obviousness-type double-patenting should apply in this case. (D.I. 74 at 7). Despite Plaintiff's assurances, the Court concludes that section "V. Opinions and Basis Therefor," subsection "A. Legal Background for Opinions" of Mr. Voight's report must be stricken because it contains inadmissible legal conclusions. (D.I. 74, Ex. A at 10-11). ORDER *2 NOW THEREFORE IT IS HEREBY ORDERED that Defendant Teva Pharmaceuticals USA, Inc.'s Motion To Preclude The Testimony Of Plaintiff's Patent Law Expert (D.I.69) is GRANTED and section V ., sub-section A., of Mr. Voight's "Amended Rebuttal Expert Report" (D.I. 74 Ex. A at 10-11), is stricken. D.Del.,2006. Proctor & Gamble Co. v. Teva Pharmaceuticals USA, Inc. Slip Copy, 2006 WL 2241018 (D.Del.) Briefs and Other Related Documents (Back to top) · 1:04cv00940 (Docket) (Aug. 13, 2004) END OF DOCUMENT

© 2006 Thomson/West. No Claim to Orig. U.S. Govt. Works.